Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho Proposes Revisions of NHI Pricing Rules
November 5, 2007
- J-TEC Aims at \1 Bil. with Japan's First Cultured Autologous Epidermis
November 5, 2007
- Conclusion Not yet Drawn on Causal Relation between Tamiflu and Abnormal Behavior
November 5, 2007
- Korosho Proposes More Fees for Treatment of Mental Illness
November 5, 2007
- Korosho to Order Revision of Package Insert for All Antidepressants
November 5, 2007
- REGULATORY NEWS IN BRIEF
October 29, 2007
- Working-Level Meeting Held on 5-Year Strategy
October 29, 2007
- Concerta Recommended for Approval, Depression to Be Deleted from Ritalin's Indications
October 29, 2007
- GSK Criticizes Media for Reports Linking Paxil with Suicides
October 29, 2007
- 30 New Products Approved, Including World's First Recombinant Human Serum Albumin
October 29, 2007
- First GL on Uterine Cervical Cancer Published
October 29, 2007
- NEW PRODUCTS／Genzyme's Elaprase Launched 261 Days after Application
October 29, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 29, 2007
- BUSINESS NEWS IN BRIEF
October 29, 2007
- OPINION／Why Problems Are Always Opportunities
October 29, 2007
- Pfizer Holds Career Planning Course for Female MRs
October 29, 2007
- Development of More Switch OTC Drugs Essential
October 29, 2007
- AstraZeneca Works to Create Easier-to-Work Environment for Female MRs
October 29, 2007
- Paltac to Stimulate OTC Drug Market by Merging with Kobashou
October 29, 2007
- MR Education Center Considers Radical Reform of MR Education System
October 29, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…